Brief: Nabriva Therapeutics PLC Says Begun Exclusive Distribution Of Sivextro (Tedizolid Phosphate) In U.S.
15/04/2021 17:26
April 15 (Reuters) - Nabriva Therapeutics PLC NBRV.O :
* NABRIVA THERAPEUTICS PLC - BEGUN EXCLUSIVE DISTRIBUTION OF
SIVEXTRO (TEDIZOLID PHOSPHATE) IN UNITED STATES
Source text for Eikon: urn:newsml:reuters.com:*:nGNXbsHbRM
Further company coverage: NBRV.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Nabriva Therapeutics
See all newsBrief: Nabriva Therapeutics And Units Enter Asset Purchase Agreement With Sumitomo Pharma
Brief: Nabriva Therapeutics Says Received Delisting Determination Letter From Nasdaq
Brief: Nabriva Therapeutics Receives Notice Of Delisting Or Failure To Satisfy Continued Listing Rule From Nasdaq
Brief: Nabriva Therapeutics - On Jan 31, Co's Unit Entered Into Letter Agreement With 2 Units Of Merck & Co, About Distribution Agreement, Dated July 15, 2020
Brief: Nabriva Therapeutics Provides Corporate Update